share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer Denton David M

SEC ·  Sep 17 01:06

Summary by Futu AI

Pfizer Inc. (PFE) has reported a transaction involving Chief Financial Officer & Executive Vice President Denton David M. The transaction, dated 09/12/2024, does not include details on the number of shares traded, the nature of the shares, the transaction price, or the total value of the shares. The report also does not specify the number of shares held by Denton after the action. The absence of this information limits the ability to assess the full impact of the transaction on Pfizer's stock.
Pfizer Inc. (PFE) has reported a transaction involving Chief Financial Officer & Executive Vice President Denton David M. The transaction, dated 09/12/2024, does not include details on the number of shares traded, the nature of the shares, the transaction price, or the total value of the shares. The report also does not specify the number of shares held by Denton after the action. The absence of this information limits the ability to assess the full impact of the transaction on Pfizer's stock.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.